Tetsuo Taguchi

Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions.

I. Hyodo, A. Ohtsu, T. Taguchi, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer.

Y. Shimada, R. Kanamaru, K. Muro, 1998, American journal of clinical oncology.

Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.

T. Taguchi, H. Niitani, K. Furuse, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Early phase II clinical study of RP56976 (docetaxel) in patients with primary pulmonary cancer. Docetaxel Cooperative Study Group for Lung Cancer].

M. Nakano, T. Ogura, Y. Kurita, 1994, Gan to kagaku ryoho. Cancer & chemotherapy.

Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.

K. Hirata, T. Taguchi, K. Sasaki, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.

H. Fujii, M. Narabayashi, K. Itoh, 1998, British Journal of Cancer.

A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.

M. Narabayashi, T. Watanabe, N. Horikoshi, 1996, British Journal of Cancer.

[Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].

T. Taguchi, Y. Shimada, M. Yoshino, 1994, Gan to kagaku ryoho. Cancer & chemotherapy.

A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies.

M. Oka, S. Saji, T. Taguchi, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--optimal dose-finding study].

T. Taguchi, H. Furue, H. Niitani, 1993, Gan to kagaku ryoho. Cancer & chemotherapy.